Tested Applications
| Positive WB detected in | LNCaP cells, A431 cells |
| Positive IHC detected in | human ovary cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
27195-1-AP targets EHF in WB, IHC, ChIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag25885 Product name: Recombinant human EHF protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-199 aa of BC038995 Sequence: MILEGGGVMNLNPGNNLLHQPPAWTDSYSTCNVSSGFFGGQWHEIHPQYWTKYQVWEWLQHLLDTNQLDANCIPFQEFDINGEHLCSMSLQEFTRAAGTAGQLLYSNLQHLKWNGQCSSDLFQSTHNVIVKTEQTEPSIMNTWKDENYLYDTNYGSTVDLLDSKTFCRAQISMTTTSHLPVAESPDMKKEQDPPAKCHT Predict reactive species |
| Full Name | ets homologous factor |
| Calculated Molecular Weight | 35 kDa |
| Observed Molecular Weight | 35 kDa |
| GenBank Accession Number | BC038995 |
| Gene Symbol | EHF |
| Gene ID (NCBI) | 26298 |
| RRID | AB_2880796 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NZC4 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
ETS homologous factor (EHF) is also named Epithelium-specific Ets transcription factor 3 (ESE-3), ESE3B and ESEJ. EHF is a member of the E26 transformation-specific (ETS) gene superfamily (PMID: 12894586). EHF as a tumour suppressor in PDAC. In PDAC, EHF promotes E-cadherin expression and suppresses epithelial-mesenchymal transition (PMID: 27923832). EHF deficiency induces the conversion and expansion of Treg cells and MDSCs by inhibiting TGFβ1 and GM-CSF secretion (PMID: 30733283). In prostate cancer, EHF plays a vital role in the inhibition of cell-intrinsic CSCs signal by suppressing STAT3 and repressing the expression of TWIST1, ZEB2, BMI1 and POU5F1 (PMID: 27732936, PMID: 22505649). EHF not only plays a cell autonomous role in regulating CSC stemness but also has important functions in regulating the sensitivity to a pro-CSC stimulus from the PSC niche (PMID: 33674341).
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for EHF antibody 27195-1-AP | Download protocol |
| WB protocol for EHF antibody 27195-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The antibody is an EHF (ETS Homologous Factor) antibody, catalog number 27195-1-AP, with a total of 10 citations. These appear in journals including Cell Biosciences, Oncogenesis, International Journal of Molecular Sciences, Journal of Clinical Endocrinology & Metabolism, BMC Cancer, Regenerative Therapy, Endocrinology, Journal of Bioenergetics and Biomembranes, American Journal of Cancer Research, and Gene. Research fields span oncology (gastric, lung, thyroid, endometrial, colon, and renal cancers), ferroptosis, transcriptional regulation, macrophage polarization, and glycolysis.
| Species | Application | Title |
|---|---|---|
Cell Biosci Cholesterol confers resistance to Apatinib-mediated ferroptosis in gastric cancer | ||
Oncogenesis Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma.
| ||
Int J Mol Sci Multiomics Reveals IL-17 Drives Epithelial Keratinization and Proliferation via EHF in Odontogenic Keratocysts. | ||
J Clin Endocrinol Metab BRAF-induced EHF expression affects TERT in aggressive papillary thyroid cancer | ||
BMC Cancer EHF as a key regulator mediating cell migration and may contribute to tumor immune infiltration and progression in human endometrial cancer.
| ||
Regen Ther Lung cancer cell-derived exosomal EHF drives M2 macrophage polarization via transcriptional activation of RNF41 to promote tumor progression.
|





